![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
2 Department of Food Science and Human Nutrition, Iowa State University, Ames, IA 50011 and 3 Canadian Institutes of Health Research Group on the Molecular and Cell Biology of Lipids and Department of Biochemistry, University of Alberta, Edmonton, Canada
* To whom correspondence should be addressed: E-mail: kschalin{at}iastate.edu.
Phosphatidylcholine is an essential phospholipid that is synthesized by 2 different pathways, the CDP-choline pathway and the methylation of phosphatidylethanolamine by phosphatidylethanolamine N-methyltransferase (PEMT). Recent studies have suggested that PEMT is an important consumer of methyl groups from S-adenosylmethionine (SAM) and is a major determinant of homocysteine pools. Diabetes and all-trans-retinoic acid (ATRA) have been shown to alter the activities of several enzymes involved in methyl group metabolism. Thus, we investigated how diabetes and ATRA, individually and together, affect SAM-dependent phospholipid methylation. Rats received a single injection of streptozotocin (60 mg/kg body wt) or vehicle followed by administration of ATRA (30 µmol/kg body wt) or vehicle for 5 d. The hepatic activity of PEMT increased 50% in both diabetic rat groups, whereas administration of ATRA was without effect. In diabetic rats, plasma total homocysteine decreased 30–35% in all treatment groups as compared with the control group. Thus, alterations in the activity of PEMT were not directly correlated to changes in homocysteine concentrations. Moreover, treatment of diabetic rats with insulin prevented the increase in PEMT activity and abundance. Because these observations support an increased need for SAM-dependent phosphatidylcholine synthesis, this may also indicate an increased choline requirement in diabetes.
This article has been cited by other articles:
|
|
 |
|
  J. Garbarino, M. Padamsee, L. Wilcox, P. M. Oelkers, D. D'Ambrosio, K. V. Ruggles, N. Ramsey, O. Jabado, A. Turkish, and S. L. Sturley Sterol and Diacylglycerol Acyltransferase Deficiency Triggers Fatty Acid-mediated Cell Death J. Biol. Chem., November 6, 2009; 284(45): 30994 - 31005. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Smilowitz, M. M. Wiest, S. M. Watkins, D. Teegarden, M. B. Zemel, J. B. German, and M. D. Van Loan Lipid Metabolism Predicts Changes in Body Composition during Energy Restriction in Overweight Humans J. Nutr., February 1, 2009; 139(2): 222 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. T. Williams, T. A. Garrow, and K. L. Schalinske Type I Diabetes Leads to Tissue-Specific DNA Hypomethylation in Male Rats J. Nutr., November 1, 2008; 138(11): 2064 - 2069. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Malanovic, I. Streith, H. Wolinski, G. Rechberger, S. D. Kohlwein, and O. Tehlivets S-Adenosyl-L-homocysteine Hydrolase, Key Enzyme of Methylation Metabolism, Regulates Phosphatidylcholine Synthesis and Triacylglycerol Homeostasis in Yeast: IMPLICATIONS FOR HOMOCYSTEINE AS A RISK FACTOR OF ATHEROSCLEROSIS J. Biol. Chem., August 29, 2008; 283(35): 23989 - 23999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Vance, Z. Li, and R. L. Jacobs Hepatic Phosphatidylethanolamine N-Methyltransferase, Unexpected Roles in Animal Biochemistry and Physiology J. Biol. Chem., November 16, 2007; 282(46): 33237 - 33241. [Full Text] [PDF]
|
|
|
|
|
|
K. T. Williams and K. L. Schalinske New Insights into the Regulation of Methyl Group and Homocysteine Metabolism J. Nutr., February 1, 2007; 137(2): 311 - 314. [Abstract] [Full Text] [PDF]
|
|
